Albert Grinshpun: Another important sub-population which might enjoy life without chemo

Albert Grinshpun, Goldfarb Advanced Breast Cancer Fellow at the Breast Oncology Center of Dana-Farber Cancer Institute shared a post by Yakub Ergün, Medical Oncologist at Antalya City Hospital on X:

“In addtion to the great data from ATEMPT by Paolo Tarantino and Sara Morishige, another important sub-population which might enjoy life without chemo.”

Quoting Yakub Ergün’s post on X:

“Tumor-Infiltrating Lymphocytes in Stage I TNBC Untreated With Chemotherapy.

Patients with pT1c TNBC tumors and sTIL levels ≥50% had a 10-year survival of 95% without chemotherapy, increasing to 98% with sTIL levels ≥75%.”

Source: Albert Grinshpun/X and Yakub Ergün/X